Chimeric antigen receptor T-cell therapy combined with autologous stem cell transplantation improved progression-free survival of relapsed or refractory diffuse large B-cell lymphoma patients: A single-center, retrospective, cohort study-MedSci.cn

Chimeric antigen receptor T-cell therapy combined with autologous stem cell transplantation improved progression-free survival of relapsed or refractory diffuse large B-cell lymphoma patients: A single-center, retrospective, cohort study

Wang, T; Xu, LL; Gao, L; Tang, GS; Chen, L; Chen, J; Wang, Y; Fu, WJ; Yue, WQ; Ye, MY; Yu, JC; Yu, XJ; Feng, DG; Zhang, AP; Yang, JM

Yang, JM (通讯作者)，Naval Mil Med Univ, Changhai Hosp, Inst Hematol, Dept Hematol, 168 Changhai Rd, Shanghai 200433, Peoples R China.

Abstract

Autologous hematopoietic stem cell transplantation (ASCT) and chimeric antigen receptor T-cell therapy (CART) are salvage therapies that are utilised ......

Full Text Link

Links

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

Chimeric antigen receptor T-cell therapy combined with autologous stem cell transplantation improved progression-free survival of relapsed or refractory diffuse large B-cell lymphoma patients: A single-center, retrospective, cohort study

科室

工具

服务